Save 20% on Press Releases and More with NNW Prime! Click to View Details
ThursdayMar 02, 2017 1:01 pm

Axim Biotechnologies (AXIM) Boosts Billion-Dollar Brand Portfolio with Launch of CanChew Plus™

Now that production of its next generation award-winning controlled-release cannabidiol (CBD) functional chewing gum, CanChew Plus™, has kicked off, Axim Biotechnologies (OTCQB: AXIM) has boosted its diverse billion-dollar product portfolio with another strong growth brand. With so many golden eggs in its brand basket, the company is expecting strong top line growth in the near future. Current revenue projections show AXIM could soon earn the rarified rank of unicorn. AXIM is looking ahead to a bright future with an uplisting to either the NYSE or NASDAQ. The company’s strong sales projections are built on a number of factors. The company’s…

Continue Reading

ThursdayMar 02, 2017 9:13 am

SinglePoint, Inc. (SING) Banking on Greener Pastures

SinglePoint, Inc. (OTC: SING) has a considerable stake in the state of the legal cannabis industry. Among other things, SinglePoint is a holding company for SingleSeed, a company that provides payment services, solutions, and support for the cannabis industry. Working in tandem, SinglePoint and SingleSeed share resources and offer non-cash payment solutions, such as: Pay by Text solutions that allow customers to pay for products using their mobile phones; point of sale terminals that provide customers the convenience of using debit/credit cards right at checkout; text mobile marketing solutions; and text message marketing. SingleSeed exists to inform and educate shopkeepers…

Continue Reading

WednesdayMar 01, 2017 2:15 pm

CytoDyn Inc.’s (CYDY) PRO 140 is One of the Most Promising Monoclonal Antibody Therapies

New forms of treatment based on monoclonal antibodies show a lot of promise for human immunodeficiency virus patients with drug resistance or limited treatment options, according to HIV/AIDS researchers at this year’s edition of the Conference on Retroviruses and Opportunistic Infections (CROI 2017), which was held last month in Seattle (http://nnw.fm/Co5Ma). Researchers focused on two monoclonal antibody therapies – PRO 140 from CytoDyn Inc. (OTCQB: CYDY) and Ibalizumab from TaiMed Biologics, both of which have shown impressive results during clinical trials as long-acting therapies for HIV patients with limited options because of HIV drug resistance. PRO 140 is currently in two…

Continue Reading

WednesdayMar 01, 2017 1:16 pm

National Waste Management Holdings, Inc. (NWMH) is Increasing Shareholder Value with Roll-Up Strategy

With over 40 years of relevant industry experience, National Waste Management Holdings, Inc. (OTC: NWMH) is on a roll. The company continues to execute a roll-up strategy that is paying huge dividends. Since 2014, NWMH has executed five M&A transactions, which have resulted in an increased customer base, a wider menu of services and a bigger top line. Now, the company is focused on increasing shareholder value by squeezing synergies from those acquisitions. NWMH’s roll-up strategy took off on June 16, 2014, after a reverse merger with Sand/Land of Florida Enterprises, Inc. (“Sandland”), which then became a wholly-owned subsidiary of…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000